Bio Protocol vs Scallop — how do they compare? Bio Protocol trades at Rp514.8 (market cap Rp1,15T, Rp256,3M 24h volume), while Scallop trades at Rp151.57 (market cap Rp24,61M, Rp1,42M 24h volume). The key difference: Bio Protocol is far larger — about 46729× Scallop's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 163M / 250M SCA (66%) for Scallop. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Scallop for 13 Days on average.
| BIO | SCA | |
|---|---|---|
Market Cap | Rp1,15T | Rp24,61M |
Volume (24h) | Rp256,3M | Rp1,42M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 163M / 250M SCA (66%) |
Typical Hold Time | 16 Days | 13 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Scallop is an advanced decentralized finance (DeFi) protocol built on the Sui blockchain. It offers a wide range of financial services, including lending, borrowing, automated market making (AMM), and asset management. Developed by Scallop Labs, which has a team of experts in DeFi, cybersecurity, and fintech, Scallop has attracted support from notable investors such as CMS Holdings, 6th Man Ventures, KuCoin Labs, and Mysten Labs. Additionally, it is the first DeFi project to receive an official grant from the Sui Foundation, highlighting its institutional-grade quality and strong security features.
Read more on SCA →